Every day at The Cutting Edge we scour through public companies in search of state-of-the-art developments.
We look for innovators poised to become the next Microsoft, the next Apple, or the next Google.
In doing so, we seek to replicate some of the biggest stock market returns of the last 20 years — 90% of which have been in technology and biotech.
Returns such as the 6,244% gain seen from Celgene Corporation (NASDAQ: CELG), 6,334% from Biogen Idec (NASDAQ: BIIB), or 9,232% from Qualcomm Inc. (NASDAQ: QCOM) — enough to turn a simple $10,000 investment into well over $9 million.
To accomplish this, we have to get in early, which is why The Cutting Edge portfolio is composed primarily of small-cap and aggressive growth stocks.
It's widely recommended that at least 20% of any portfolio should be allocated to small-cap stocks. This is our area of expertise.
Most investors aren't able to dedicate the amount of time and resources required to execute successful small-cap trades. Small-cap investing requires a great deal of research, which is why it's our mission at The Cutting Edge to cut through the noise so you don't have to.
We pay for industry reports, read through SEC filings, and trade on a unique selection of technical triggers to save you the hassle.
We break down technology into accessible terms so you can fully understand what you're investing in, and we trade on major events that could as much as double share value in a matter of days.
For each trade, we explain our decision-making process in clear and concise terms. We make sure you understand exactly why every trade is being executed on both the fundamental and the technical level.
With every trade recommendation, you'll receive an exclusive, highly detailed report including:
Normally, The Cutting Edge has a list price of $2,000, but you'll only pay $1,499 for a full year if you order here today.
That's $500 in savings.
As a subscriber to The Cutting Edge, you'll also receive:
Access VIP Service— A subscription to The Cutting Edge qualifies you for VIP service. You can contact the VIP team with any questions at (844) 310-4115.
We're even throwing in three free bonus reports, detailing our most popular stock recommendations at the time of your signup.
Most importantly, we'd like to give you a chance to make the best decision for yourself. That's why if you sign up today you'll get a 30-day free trial to The Cutting Edge. If you decide the subscription isn't for you, just give us a call and we'll refund every penny.
In other words, there's no obligation for your first month.
The opportunities you'll see in the coming days are breathtaking and could put you on the track to massive gains. Please don't miss out...
The order form below is 100% secure. I hope to hear from you soon. In fact, if you want to get started right away using our system or if you have any questions, please call our Customer Care Team at 1-877-303-4529.
There's only one thing left to do: Subscribe to The Cutting Edge today. Try it for the next 30 days.